DelveInsight's "EMPAVELI Market Size, Forecast, and Market Insight Report" highlights the details around EMPAVELI, a ...
EMPAVELI's unique mechanism of targeting C3 broadens its applicability beyond PNH, including other complement-driven diseases like geographic atrophy and immune complex-mediated diseases. With ...
A protocol for transitioning patients with heart failure and a left ventricular assist device to a stepdown unit from the ICU ...
Michael Bromberg, MD, PhD, talks with Physician’s Weekly about renal disease in patients with paroxysmal nocturnal ...
The Ga Mantse, King Tackie Teiko Tsuru II, has taken the lead to tackle neonatal health challenge, particularly neonatal ...
However, when you mix your sample manually, make sure you don’t mix it too vigorously to reduce the risk of hemolysis.[1] Using automatic mixing integrated in your blood gas analyzer aids in ...
Intensive phototherapy successfully treated a newborn with hemolytic disease of the fetus and newborn (HDFN) caused by ABO ...
Normal 0.2%-2% 0%-0.9% 0.5%-2.5% ...
A 65-year-old male presented for his annual exam. The medical assistant (MA) checking the patient in remarked that he is asymptomatic except for reporting being a little bit more fatigued than usual.
The FDA first approved eculizumab for use in adult patients with generalized myasthenia gravis in 2017, before expanding the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback